{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ,        { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Rostlinn\u00E9 alkaloidy a jin\u00E1 p\u0159\u00EDrodn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01CD",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Taxany" , "@language" : "cs" } ,        { "@value" : "Taxanes" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01CD" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01CD02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L01C" ,        "http://linked.opendata.cz/resource/ATC/L" ,        "http://linked.opendata.cz/resource/ATC/L01" ,        "http://linked.opendata.cz/resource/ATC/L01CD" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Docetaxel" , "@language" : "en" } ,        { "@value" : "Docetaxel" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01CD02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Neutropenie" , "@language" : "cs" } ,        { "@value" : "Neutropenia" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Thrombocytopenia" , "@language" : "en" } ,        { "@value" : "Trombocytopenie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0184558",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Docetaxel" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/D" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/DOCETAXEL-STADA-20-MG-0-5-ML-KONC--A-ROZP--PRO-PRIPRAVU-INF--ROZTOKU",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0184558" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DOCETAXEL STADA 20 MG/0,5 ML KONC. A ROZP. PRO P\u0158\u00CDPRAVU INF. ROZTOKU" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01CD02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/D" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0176465" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0176465",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DOCETAXEL STADA 20 MG/0,5 ML KONC. A ROZP. PRO P\u0158\u00CDPRAVU INF. ROZTOKU" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01CD02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC134259_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1X0.5ML+1.5ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "20MG+1.5ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Karcinom prsu\nDocetaxel STADA v kombinaci s doxorubicinem a cyklofosfamidem je indikov\u00E1n k adjuvantn\u00ED l\u00E9\u010Db\u011B\nnemocn\u00FDch s operabiln\u00EDm karcinomem prsu s pozitivn\u00EDmi uzlinami.\nDocetaxel STADA v kombinaci s doxorubicinem je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s lok\u00E1ln\u011B pokro\u010Dil\u00FDm nebo metastazuj\u00EDc\u00EDm karcinomem prsu, kte\u0159\u00ED nebyli pro toto onemocn\u011Bn\u00ED dosud l\u00E9\u010Den\u00ED cytotoxickou l\u00E9\u010Dbou.\nDocetaxel STADA v monoterapii je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s lok\u00E1ln\u011B pokro\u010Dil\u00FDm nebo metastazuj\u00EDc\u00EDm karcinomem prsu po selh\u00E1n\u00ED p\u0159edchoz\u00ED cytotoxick\u00E9 l\u00E9\u010Dby. P\u0159edchoz\u00ED l\u00E9\u010Dba by m\u011Bla zahrnovat antracyklin nebo alkyla\u010Dn\u00ED l\u00E1tku.\nDocetaxel STADA v kombinaci s trastuzumabem je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s\u00A0metastatick\u00FDm karcinomem prsu, u n\u011Bho\u017E je prok\u00E1z\u00E1na overexprese HER2 a kte\u0159\u00ED dosud nebyli l\u00E9\u010Deni chemoterapi\u00ED pro metastatick\u00E9 onemocn\u011Bn\u00ED.\nDocetaxel STADA v kombinaci s capecitabinem je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s lok\u00E1ln\u011B pokro\u010Dil\u00FDm nebo metastazuj\u00EDc\u00EDm karcinomem prsu po selh\u00E1n\u00ED p\u0159edchoz\u00ED cytotoxick\u00E9 l\u00E9\u010Dby. P\u0159edchoz\u00ED l\u00E9\u010Dba by m\u011Bla zahrnovat antracyklin.\nNemalobun\u011B\u010Dn\u00FD karcinom plic\nDocetaxel STADA je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s lok\u00E1ln\u011B pokro\u010Dil\u00FDm nebo metastazuj\u00EDc\u00EDm nemalobun\u011B\u010Dn\u00FDm karcinomem plic po selh\u00E1n\u00ED p\u0159edchoz\u00ED chemoterapie.\nDocetaxel STADA v kombinaci s cisplatinou je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s neresekovateln\u00FDm, lok\u00E1ln\u011B pokro\u010Dil\u00FDm nebo metastazuj\u00EDc\u00EDm nemalobun\u011B\u010Dn\u00FDm karcinomem plic, kte\u0159\u00ED dosud pro toto onemocn\u011Bn\u00ED nebyli l\u00E9\u010Den\u00ED chemoterapi\u00ED.\nKarcinom prostaty\nDocetaxel STADA v kombinaci s prednizonem nebo prednizolonem je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s metastatick\u00FDm karcinomem prostaty neodpov\u00EDdaj\u00EDc\u00EDm na hormon\u00E1ln\u00ED l\u00E9\u010Dbu.\nAdenokarcinom \u017Ealudku\nDocetaxel STADA v kombinaci s cisplatinou a 5-fluorouracilem je indikov\u00E1n k l\u00E9\u010Db\u011B nemocn\u00FDch s metastatick\u00FDm adenokarcinomem \u017Ealudku v\u010Detn\u011B adenokarcinomu gastroesofage\u00E1ln\u00EDho spojen\u00ED, kte\u0159\u00ED dosud pro metastatick\u00E9 onemocn\u011Bn\u00ED nebyli l\u00E9\u010Deni chemoterapi\u00ED.\nKarcinom hlavy a krku\nDocetaxel STADA je v kombinaci s cisplatinou a 5-fluorouracilem indikov\u00E1n k induk\u010Dn\u00ED l\u00E9\u010Db\u011B pacient\u016F s lok\u00E1ln\u011B pokro\u010Dil\u00FDm dla\u017Edicobun\u011B\u010Dn\u00FDm karcinomem hlavy a krku.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 7006.06982421875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 2265.159912109375 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF CSL LQF 1X0.5ML/20MG+1.5ML" , "@language" : "cs" } ] }] }